secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2025-01-27T23:59:59+00:00
Accession:  0001654954-25-000805
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience issues 191,698 shares, raises ~$1.5M from accredited investor since Nov 2024
--------------------------------------------------------------------------------

- Sold 75,000 shares at $20.19 each to one accredited investor, gross proceeds ~$1.5M.
- Granted 38,478 restricted shares to non-employee directors under 2024 Equity Incentive Plan.
- Issued 78,320 shares to investors under Exchange Program in exchange for cancellation of co-development agreements.
- Total shares outstanding as of Jan 20, 2025: 3,738,033.
- Shares issued in unregistered transactions exempt under Section 4(a)(2) and Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425000805/0001654954-25-000805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425000805/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-000805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer